Gene · 4060
Papers3,622
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,622
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analysis of matrisome expression patterns in murine and human dorsal root ganglia. | Front Mol Neurosci | 2023 | 37664243 | PubTator, text mining | PubMed |
| Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix. | Front Immunol | 2023 | 37662958 | PubTator, text mining | PubMed |
| Identification and experimental validation of key extracellular proteins as potential targets in intervertebral disc degeneration. | Bone Joint Res | 2023 | 37661086 | PubTator, text mining | PubMed |
| Single-cell analysis of human prepuce reveals dynamic changes in gene regulation and cellular communications. | BMC Genomics | 2023 | 37658288 | PubTator, text mining | PubMed |
| An insight into the potential role of LINC00968 in luminal breast cancer: Case-control study and bioinformatics analysis. | Biochem Biophys Rep | 2023 | 37654678 | PubTator, text mining | PubMed |
| Photo-click hydrogels for 3D in situ differentiation of pancreatic progenitors from induced pluripotent stem cells. | Stem Cell Res Ther | 2023 | 37649117 | PubTator, text mining | PubMed |
| Unraveling the transcriptome-based network of tfh cells in primary sjogren syndrome: insights from a systems biology approach. | Front Immunol | 2023 | 37638029 | PubTator, text mining | PubMed |
| Human fetal dermal fibroblast-myeloid cell diversity is characterized by dominance of pro-healing Annexin1-FPR1 signaling. | iScience | 2023 | 37636079 | PubTator, text mining | PubMed |
| Spatially Resolved Transcriptomics Technology Facilitates Cancer Research. | Adv Sci (Weinh) | 2023 | 37632718 | PubTator, text mining | PubMed |
| Locoregional Therapies and Remodeling of Tumor Microenvironment in Pancreatic Cancer. | Int J Mol Sci | 2023 | 37628865 | PubTator, text mining | PubMed |
| Contemporary Biomarkers for Renal Transplantation: A Narrative Overview. | J Pers Med | 2023 | 37623466 | PubTator, text mining | PubMed |
| Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism. | Sci Rep | 2023 | 37612324 | PubTator, text mining | PubMed |
| Robust dimethyl-based multiplex-DIA doubles single-cell proteome depth via a reference channel. | Mol Syst Biol | 2023 | 37602975 | PubTator, text mining | PubMed |
| Pancancer network analysis reveals key master regulators for cancer invasiveness. | J Transl Med | 2023 | 37599366 | PubTator, text mining | PubMed |
| Rapid RGR-dependent visual pigment recycling is mediated by the RPE and specialized Müller glia. | Cell Rep | 2023 | 37585292 | PubTator, text mining | PubMed |
| Epithelial-Mesenchymal Transition Mechanisms in Chronic Airway Diseases: A Common Process to Target? | Int J Mol Sci | 2023 | 37569787 | PubTator, text mining | PubMed |
| Molecular Biomarkers for the Diagnosis, Prognosis, and Pharmacodynamics of Spinal Muscular Atrophy. | J Clin Med | 2023 | 37568462 | PubTator, text mining | PubMed |
| Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer. | Medicine (Baltimore) | 2023 | 37565899 | PubTator, text mining | PubMed |
| 3D bioprinting of corneal decellularized extracellular matrix: GelMA composite hydrogel for corneal stroma engineering. | Int J Bioprint | 2023 | 37555081 | PubTator, text mining | PubMed |
| Unraveling the Relevance of Tissue-Specific Decellularized Extracellular Matrix Hydrogels for Vocal Fold Regenerative Biomaterials: A Comprehensive Proteomic and In Vitro Study. | Adv Nanobiomed Res | 2023 | 37547672 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4060/papers?page=21